SemaThera Employee Directory

SemaThera corporate office is located in 1 Av Du Mont-Royal O Suite 800, Montreal, Quebec, H2T 2R9, Canada and has 1-10 employees.

Employees by Department

Departments

Number of employees

Engineering & Technical

3

Operations

1

C-Suite

1

SemaThera CEO

Garth Cumberlidge, President & Director & Chief Executive Officer at SemaThera
Canada flag for contact location.
Garth CumberlidgePresident & Director & Chief Executive Officer
PhonePhoneEmailEmail
See Profile

Key Employees of SemaThera

  • VB
    Canada flag for contact location.
    Véronique Boug...

    Consulting Chief Operating Officer

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

SemaThera Global Presence

globalPresence illustration
North America1-10

Index of contact profiles from SemaThera

Hundreds of professionals searching for SemaThera have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at SemaThera

Explore people who held key positions, contributed to SemaThera's success, and advanced their careers.

  1. MSL Ophthalmology at Bausch & Lomb

    Worked as Team Project Leader

    at SemaThera (2021-2023)

    email François Binet Email direct François Binet Direct

Explore More

People from Similar Companies in the Business Services Industry Located in Canada

Frequently Asked Questions Regarding SemaThera Employees

How many employees does SemaThera have?
SemaThera has 1-10 employees
Who is the CEO of SemaThera?
SemaThera’s CEO is Garth Cumberlidge
Who are SemaThera key employees?
Some of SemaThera key employees are Véronique Bougie
Where is SemaThera located?
SemaThera’s headquarters are located at 1 Av Du Mont-Royal O Suite 800, Montreal, Quebec, H2T 2R9, Canada
How do I contact SemaThera?
SemaThera Contact Info: Website: www.semathera.com
What does SemaThera do?

SemaThera Inc. is focused on developing innovative treatments for diabetic and other retinal degenerative diseases, addressing the significant impact of diabetes on vision. The company has conducted over a decade of research into the role of semaphorin 3A in diabetic retinopathy, leading to the creation of biological traps that sequester harmful pr... oteins and cytokines. Their products aim to reduce retinal vascular leakage, inflammation, and promote re-vascularization in affected patients. SemaThera collaborates with leading organizations, including a partnership with Roche, to advance their therapeutic solutions.Read More

Is SemaThera a public company?
SemaThera is private company therefore does not currently have an official ticker symbol
See more information about SemaThera Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.